Literature DB >> 17960104

Two novel lanostane triterpenoids from Ganoderma sinense.

Yin Qiao1, Xian-min Zhang, Ming-hua Qiu.   

Abstract

Two novel lanostane-type triterpenes, Ganolactone B and Ganoderiol A triacetate, were isolated from the fruiting bodies of G. sinense, together with six known compounds. The structures of the two new triterpenes were determined as 3beta,7beta- dihydroxy-11,15-dioxo-lanosta-8-en-24-->20 lactone (1) and 3beta,24,26-triacetoxy-5alpha-lanosta-7,9(11)-dien-25-ol (2), respectively, by chemical and spectroscopic means.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17960104      PMCID： PMC6149161          DOI： 10.3390/12082038

Source DB:  PubMed          Journal:  Molecules        ISSN： 1420-3049            Impact factor:   4.411


  6 in total

1.  [Studies on the ganoderic acid, a new constituents from the fruiting body of Ganoderma lucidum (Fr.) Karst].

Authors:  F S Wang; H Cai; J S Yang; Y M Zhang; C Y Hou; J Q Liu; M J Zhao
Journal:  Yao Xue Xue Bao       Date:  1997-06

2.  Oxygenated lanostane-type triterpenoids from the fungus ganodermalucidum.

Authors:  Toshihiro Akihisa; Masaaki Tagata; Motohiko Ukiya; Harukuni Tokuda; Takashi Suzuki; Yumiko Kimura
Journal:  J Nat Prod       Date:  2005-04       Impact factor: 4.050

3.  The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes.

Authors:  H Kohda; W Tokumoto; K Sakamoto; M Fujii; Y Hirai; K Yamasaki; Y Komoda; H Nakamura; S Ishihara; M Uchida
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-04       Impact factor: 1.645

4.  Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum.

Authors:  A Morigiwa; K Kitabatake; Y Fujimoto; N Ikekawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-07       Impact factor: 1.645

5.  Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease.

Authors:  B S Min; N Nakamura; H Miyashiro; K W Bae; M Hattori
Journal:  Chem Pharm Bull (Tokyo)       Date:  1998-10       Impact factor: 1.645

6.  Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide.

Authors:  Qi-Zhen Cao; Zhi-Bin Lin
Journal:  Acta Pharmacol Sin       Date:  2004-06       Impact factor: 6.150
  6 in total
  1 in total

1.  Submerged fermentation production and characterization of intracellular triterpenoids from Ganoderma lucidum using HPLC-ESI-MS.

Authors:  Mei-lin Cui; Huan-yi Yang; Guo-qing He
Journal:  J Zhejiang Univ Sci B       Date:  2015-12       Impact factor: 3.066
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.